Contact UsInvestorsCareersMediaScienceContact Us
HomeAboutPfizer ChinaChina Overview

Since entering the Chinese market in 1989, Pfizer has operated in China for 36 years and now has become one of the leading foreign pharmaceutical companies in China. So far, Pfizer has a presence in over 300 cities nationwide in China. Pfizer has established 1 state-of-the-art manufacturing facility, 3 R&D centers (in Shanghai Zhangjiang High-Tech Park, Wuhan Biolake – the national biological industrial base and the Bio-Park International Pharmaceutical Innovation Park in the Beijing Economic-Technological Development Area respectively) and 1 Pfizer Innovation Center (in Hangzhou). We have introduced over 80 innovative drugs and vaccines into China. Our strong product lines are developed to meet diverse needs in every stage of life. Currently, we focus on six major therapeutic areas including Oncology, Anti-infectives, Inflammation & Immunology, Rare Disease, Migraine and Vaccines. Focusing on the needs of patients, Pfizer actively provides high-quality innovative products and solutions to Chinese patients. 

For years, we strive to “become an essential part of China healthcare system”, working together with all sectors of the society by using our global resources to actively boost the healthcare industry in China. 

1989

Pfizer established the first China-based plant in Dalian, which was the first GMP-certified pharmaceutical plant in China.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

1995

Pfizer established the pharmaceutical plant in Wuxi.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

1997

Pfizer set up the Management Center in Beijing.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2004

Pfizer established Pfizer Investment Co., Ltd. in Shanghai.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2005

Pfizer established Pfizer China R&D Center in Shanghai.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2007

Pfizer established Pfizer Finance Share Service (Asia-Pacific).

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2010

Pfizer established the R&D Center at Wuhan Biolake.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2011

Pfizer China reported to Pfizer Corporate directly, further highlighting the emphasis on the Chinese market.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

2021

Pfizer starts the new journey. Pfizer is becoming a science-based, innovative and patient-focused biopharmaceutical company.

Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.

Pipeline CareersPublicity of Medical RepresentativesPfizer Medical Information PfizerPro for Professionals Grant Seekers Media Terms of UseContact Us Business to Business © 2022 Pfizer Inc. All rights reserved 沪公网安备31010602006040 沪ICP备11000910号-2 药监批号(沪)-非经营性-2016-0003